(Q43035161)

12 November 2017

title

High prevalence of hepatitis C virus antibody and RNA in patients with oral cancer (English)

1 reference

lip and oral cavity carcinoma

12 November 2017

1 reference

1 reference

1 reference

1 reference

Nagao Y

1

1 reference

12 November 2017

Sata M

2

1 reference

12 November 2017

Tanikawa K

3

1 reference

12 November 2017

Itoh K

4

1 reference

12 November 2017

Kameyama T

5

1 reference

12 November 2017

publication date

1 September 1995

1 reference

Journal of Oral Pathology & Medicine

12 November 2017

published in

1 reference

12 November 2017

volume

24

1 reference

12 November 2017

issue

8

1 reference

12 November 2017

page(s)

354-360

1 reference

Gene amplification and overexpression of EGF receptor in squamous cell carcinomas of the head and neck

12 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0714.1995.TB01199.X

Detection of human papillomavirus genes in human oral tissue biopsies and cultures by polymerase chain reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0714.1995.TB01199.X

Hepatitis C virus RNA in saliva

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0714.1995.TB01199.X

Transmission of hepatitis C by saliva

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0714.1995.TB01199.X

HCV in saliva of chronic hepatitis patients having dental treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0714.1995.TB01199.X

Hepatitis C virus infection is an additive risk factor for development of hepatocellular carcinoma in patients with cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0714.1995.TB01199.X

Membranoproliferative glomerulonephritis associated with hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0714.1995.TB01199.X

Immunological disorders in C virus chronic active hepatitis: a prospective case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0714.1995.TB01199.X

Specificity of anti-HCV ELISA assessed by reactivity to three immunodominant HCV regions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0714.1995.TB01199.X

Oral mucosal cytomegalovirus as a manifestation of the acquired immune deficiency syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0714.1995.TB01199.X

Mutations in the p53 gene occur in diverse human tumour types

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0714.1995.TB01199.X

Activating mutations for transformation by p53 produce a gene product that forms an hsc70-p53 complex with an altered half-life

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0714.1995.TB01199.X

Elevated P53 expression correlates with a history of heavy smoking in squamous cell carcinoma of the head and neck.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0714.1995.TB01199.X

Mutational hot spot in the p53 gene in human hepatocellular carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0714.1995.TB01199.X

Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0714.1995.TB01199.X

10.1111/J.1600-0714.1995.TB01199.X

21 January 2018

Identifiers

DOI

1 reference

12 November 2017

1 reference